Sign in

CIK 0002029039

  • Non-accelerated filer
  • Emerging growth company

Nasus Pharma Ltd

Sign in to watch
Ticker
NSRX
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Israel
Entity type
Other
EIN
516022712
Phone
+972 542553956
Business address
29 HARAKEVET ST, TEL AVIV - YAFO, Israel, 6618003
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-10-08 O'Grady Brendan P. Chief Executive Officer Grant or award · Share options (right to buy) +210,000 210,000
2026-06-17 Teleman Dan Benjamin Chief Executive Officer Purchase +6,550 $3.10 $20K 163,541
2026-04-22 Teleman Dan Benjamin Chief Executive Officer Purchase +2,900 $3.76 $11K 156,991
2026-03-31 Teleman Dan Benjamin Chief Executive Officer Purchase +15,000 $2.04 $31K 21,246

Page 1 of 1 · 4 trades